So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| AcroQoL: Bảng câu hỏi về chất lượng cuộc sống trong bệnh to đầu chi× | ThyPRO: Thang đo Kết quả do Bệnh nhân Báo cáo về Bệnh Tuyến giáp× | |
|---|---|---|
| Lĩnh vực | Nội tiết học | Nội tiết học |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 2006 | 2009 |
| Người khởi xướng≠ | Markus Buchfelder, Dieter Weigel, Monica Droste, et al. | Torquil Watt, Jens Bjørner, Marianne Groenvold |
| Loại | Patient self-report questionnaire | Patient self-report questionnaire |
| Công trình gốc≠ | Buchfelder, M., Weigel, D., Droste, M., et al. (2006). The quality of life of acromegaly patients is markedly impaired: Data from the German Acromegaly Registry. Eur J Endocrinol, 150(4), 541-549. link ↗ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ |
| Tên gọi khác | Acromegaly QoL, Acro-QoL | ThyPRO-85, ThyPRO-39 |
| Liên quan | 3 | 3 |
| Tóm tắt≠ | AcroQoL is a disease-specific 22-item quality of life questionnaire developed to assess the multidimensional burden of acromegaly, a chronic growth hormone-secreting pituitary tumor disorder. Developed by Buchfelder and colleagues in 2006, it captures physical complications (joint/bone pain, carpal tunnel syndrome, metabolic disease), appearance-related concerns (facial changes, hand/foot enlargement), and psychological/social impacts (mood, social limitation, body image). It is the primary outcome measure for assessing quality of life in acromegaly treatment trials and clinical practice. | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. |
| ScholarGateBộ dữ liệu ↗ |
|
|